Stock Comparison
ARGX vs MRNA
argenx NV ADR and Moderna Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$53.23B
$25.14B
P/E (TTM)
32.7
—
Forward P/E
30.4
24.5
Price/Sales
10.0
11.3
Price/Book
6.4
3.7
EV/EBITDA
27.6
4.9
Dividend Yield
—
—
Profitability
Net Margin
30.44%
-141.43%
Operating Margin
27.34%
-149.01%
Return on Equity
23.60%
-39.00%
Return on Assets
11.60%
-13.30%
Growth (YoY)
Revenue Growth
59.30%
2.10%
Earnings Growth
95.20%
-85.10%
Price & Risk
Beta
-0.0
0.9
52-Week High
$939.68
$81.80
52-Week Low
$652.43
$22.36
Analyst Target
$1,085.78
$50.84
Compare ARGX and MRNA your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.